Updates from the field on our TB-MDR Project

2 August 2018

Carrie Tudor
  • Dr Carrie Tudor, Director of the ICN TB Project. attended the Guideline Development Group Meeting to revise the WHO treatment guidelines for rifampicin- and multidrug-resistant tuberculosis, 2018 update, in Switzerland, 16-20 July 2018. For over 20 years WHO has developed treatment guidance for drug-resistant TB to help countries address these challenges. The latest evidence-based guidance for the treatment of MDR/RR-TB was published by WHO in October 2016. The purpose of this meeting was to review the evidence for the treatment of MDR/RR-TB and make recommendations on the composition and duration of suitable treatment regimens.
  • Dr Carrie Tudor, Director of the ICN TB Project participated in the Association of Nurses in AIDS Care (ANAC) pre-conference session at the International AIDS Society meeting in Amsterdam. She was invited to participate in a panel session on TB care and treatment. ICN shared a booth with ANAC and promoted upcoming ICN events.
  • ICN has received a grant from the Stop TB Partnership’s highly competitive TB Reach mechanism to support development of the ICN Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment. The ICN guide is being developed by nurses with experience in the clinical care and programmatic management of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in both high- and low-resource settings. Nursing and DR-TB literature have been reviewed to establish best practice nursing assessment and intervention guidance. Nurses caring for patients with DR-TB have field tested the job aid and provided feedback which is being used to inform final content and format.
  • Leading Lightsread the latest newletter